Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Swedbank’s Interim report for the second quarter 2024

Swedbank´s President and CEO Jens Henriksson comments: ”We create value for our customers and shareholders”.· Strong profitability and high cost efficiency  · Solid credit quality with recoveries during the quarter  · Leading position in mortgages  Contact:Annie Ho (Annie.Ho@swedbank.se), Head of Investor Relations, +46 70 343 78 15 Hannes Mård (Hannes.mard@swedbank.se), Media Relations Manager, +46 73 057 41 95 This information constitutes inside information that Swedbank is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The

Notice of annual general meeting in EQL Pharma AB

The shareholders of EQL Pharma AB, Reg. No. 556713-3425, are hereby invited to the annual general meeting to be held on Monday 19 August 2024 at 16.00 at the company’s premises at Stortorget 1 in Lund.Right to participate and notification Shareholders wishing to attend the annual general meeting must: · be registered in the company’s share register kept by Euroclear Sweden AB as of Friday 9 August 2024, and · notify the company of their intention to participate in the annual general meeting no later than Tuesday 13 August 2024 in writing by mail to EQL Pharma AB, Stortorget 1, SE-

New data report by Smartvatten shows over 50% of residential buildings experience water leakage monthly

The Annual Water Report, based on global water data combined with Smartvatten’s database of 20,000 properties and 200,000 apartments in 36 countries, shows consistent water leakages in both residential and commercial buildings. This potentially causes hundreds of thousands of extra costs for property owners annually. The rise in water prices, extreme weather conditions, and new EU regulations have made understanding water in 2024 more important than ever.Helsinki, Finland (July 16th, 2024) Smartvatten , the leading water data provider, has published its third

SEB’s results for the second quarter 2024

SEB’s operating profit for the second quarter 2024 amounted to SEK 11.8bn, with a return on equity of 17.6 per cent, a CET1 capital ratio of 19.0 per cent, and a capital management buffer of 430 basis points.  “Our result remained solid in the second quarter and asset quality was robust. While the interest rate cuts during the quarter resulted in a decrease in net interest income, we saw improved momentum in other parts of our business. For instance, we saw positive net flows in asset management across the divisions, an increase in investment banking activity and signs of improving

LUNDIN GOLD ANNOUNCES CFO TRANSITION

Vancouver, BC, July 15, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") announced today that Christopher Kololian, Chief Financial Officer, will be departing the Company on August 15, 2024. Chester See, Lundin Gold’s Senior Vice President Finance, will assume the role of CFO. Ron Hochstein, President and Chief Executive Officer of Lundin Gold stated, "On behalf of the Board of Directors and Lundin Gold, I would like to thank Christopher for his executive leadership and contributions since joining our management team. During

The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company’s commitments under incentive programmes

The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi[®]) on 14 May 2024, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programmes resolved by the Annual General Meeting – on directed share issues of no more than 1,641,103 redeemable and convertible class C shares.The Annual General Meeting also resolved to authorise the Board of Directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class C shares. Repurchase under this authorisation may be made on one or

Aker Solutions ASA: Transactions made under the buy-back programme

July 15, 2024 – On February 12, 2024, Aker Solutions ASA (“Aker Solutions”) announced a share buy-back program of up to NOK 500 million, with a maximum of 12.5 million shares, in the period from 12 February 2024 to 31 July 2024.Upon the successful completion of the transactions below, Aker Solutions has fulfilled the objectives of the share buy-back program. DNB, acting under an irrevocable mandate from Aker Solutions, has carried out the following transactions under the buy-back program:   +--------------------+----------+-------------+-----------------------+| Date

SEB completes latest share buyback programme and initiates new programme

SEB has completed its latest share buyback programme, under which SEK 2 billion of Class A shares have been repurchased. The Board of Directors has resolved to utilise the authorisation granted by the 19 March 2024 Annual General Meeting to initiate a new SEK 2.5 billion buyback programme of Class A shares.  On 19 March 2024, SEB announced a SEK 2 billion share buyback programme for capital management purposes. The repurchases of shares began on 20 March 2024 and ended on 12 July 2024. During this period, SEB repurchased 13,329,653 of its own Class A shares at an average price per share

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization

Oslo, Norway, July 15, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has entered into a strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) reusable flexible blue light cystoscope based on Richard Wolf’s System blue technology. The partnership between Photocure and Richard Wolf is focused on developing technologically advanced flexible blue light cystoscopy (BLC[®]) equipment for the global market so that physicians who treat patients with bladder cancer can offer the benefits of BLC with

Relais Group Plc: Share Repurchase 15.7.2024

Relais Group Plc  ANNOUNCEMENT  15.7.2024 Relais Group Plc: Share Repurchase 15.7.2024 In the Helsinki Stock Exchange Trade date           15.7.2024Bourse trade         BuyShare                  RELAISAmount             650 SharesAverage price/ share    13,5000 EURTotal cost            8 775,00 EUR Relais Group Plc now holds a total of 33 657 sharesincluding the shares repurchased on 15.7.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Exel Composites Plc: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act

EXEL COMPOSITES PLC          STOCK EXCHANGE RELEASE        15 JULY 2024 AT 18:00 EESTExel Composites Plc has on 15 July 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of funds managed by OP Fund Management Company Ltd has decreased below 5% of the voting rights and share capital in Exel Composites Plc. Through share transactions concluded on 12 July 2024, the holding of funds managed by OP Fund Management Company Ltd amounts to 5,334,412 shares representing 4.998% of the shares and voting rights of Exel

#24-251 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-250 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Storskogen receives consent from bondholders in written procedures

Storskogen Group AB (publ) (“Storskogen”) announces that the written procedures (the “Written Procedures”) which were initiated on 26 June 2024 under the terms and conditions for Storskogen’s outstanding bonds 2021/2025 (ISIN: SE0017084650), bonds 2023/2027 (ISIN: SE0020358026) and bonds 2024/2027 (ISIN: SE0022240974) (the “Terms and Conditions” and the “Bonds” respectively) have been successfully concluded. The Written Procedures were initiated in connection with the decision to divest nine business units, as announced in the press release on 25 June 2024. This divestment was undertaken

Buy-back of shares in Hemnet during 8 - 12 July, 2024

Hemnet Group AB (publ) (LEI code: 5493008VIU67J3HUAR07) ("Hemnet") has during 8 to 12 July 2024 repurchased in total 16,000 own ordinary shares (ISIN code: SE0015671995) as part of the share buy-back program initiated by the board of directors of Hemnet in order to adjust Hemnet's capital structure.The share buy-backs form part of the share buy-back program of maximum SEK 450,000,000 announced by Hemnet on 25 April 2024. The share buy-back program is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU)

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003322319 Issuer Name FIDELITY ASIAN VALUES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Rathbones Investment Management Ltd City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom +------------------------+----------+----------------------------+|Name |City of |Country

Fiven ASA publishes sustainability-linked bond progress report

As announced on 21 June 2024, Fiven ASA ("Fiven") intends to redeem its outstanding EUR 110,000,000 senior secured sustainability-linked floating rate bonds with ISIN SE0021148764 (the "Bonds"). In accordance with the terms and conditions for the Bonds (the "Terms and Conditions"), a Sustainability-Linked Bond Progress Report (as defined in the Terms and Conditions) has been published as of today and is available on Fiven's website. Fiven will publish a separate call notice before the redemption of the Bonds in accordance with Terms and Conditions.     For further information,

KlaraBo acquires residential properties and divests commercial properties to Diös Fastigheter

KlaraBo has today signed an agreement to acquire the properties Hälsinggården 12:1 and 1:341 in Falun. These properties are purely residential, fitting well into KlaraBo’s business model of value-creating management. The acquisition includes 80 apartments, with an area of 5,800 sqm, and an underlying value of 80 million SEK, with 80 percent of the apartments estimated to have renovation potential. The rental value amounts to SEK 7 million, and the acquisition is made through a newly established company. Simultaneously, KlaraBo is divesting the properties Skräddaren 2 and Sigge 5 in

CS MEDICA Announces Strategic Partnerships to Enhance Funding

Securing New Capital and Strengthening Shareholder Relations Through Strategic CollaborationsCS MEDICA, a pioneering MedTech company specializing in pain management and autoimmune diseases with innovative substance-based medical devices containing bioactive CBD, announces a direct issue of 1.5 MDKK with Börsjakten AB at a share price of 3.00 DKK. This initiative is part of our broader strategy to secure short-term capital while preparing for a larger funding round, pending approval at the upcoming EGM. Additionally, we are excited to unveil three strategic collaborations aimed at enhancing

There are no items matching the current filter
There are no more items matching the current filter
Back to top